Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Food, Beverage & Tobacco
Create a narrative
Philip Morris International Community
NYSE:PM Community
3
Narratives
written by author
0
Comments
on narratives written by author
141
Fair Values set
on narratives written by author
Community Investing Ideas
Philip Morris International
Popular
Undervalued
Overvalued
Philip Morris International
AN
AnalystHighTarget
Consensus Narrative from 16 Analysts
Emerging Markets And Urban Growth Will Drive Smoke-Free Expansion
Key Takeaways Aggressive growth in ZYN and smoke-free products, alongside rapid emerging market expansion, is poised to unlock sustained revenue and market share gains beyond expectations. Broadening into wellness, healthcare, and digital platforms diversifies revenue streams and customer engagement, supporting long-term margin expansion and industry leadership.
View narrative
US$220.00
FV
24.3% undervalued
intrinsic discount
10.65%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Philip Morris International
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Smoke-Free Alternatives Will Drive Global Opportunity In Emerging Markets
Key Takeaways Accelerating global adoption of smoke-free products and regulatory support are driving strong growth, margin expansion, and lower regulatory risks for the company. Investment in digital channels and geographic diversification is boosting consumer engagement, sales effectiveness, and earnings stability across emerging and established markets.
View narrative
US$186.50
FV
10.7% undervalued
intrinsic discount
8.05%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
71
users have followed this narrative
5 days ago
author updated this narrative
Philip Morris International
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Regulatory Hurdles And Declining Demand Will Undermine Prospects
Key Takeaways Intensifying public health sentiment and regulatory hurdles threaten both traditional and next-generation product growth, challenging future revenue and operating margins. ESG-driven divestment and heavy investment requirements are increasing costs and margin pressure, especially if consumer adoption or regulatory approvals disappoint.
View narrative
US$151.00
FV
10.3% overvalued
intrinsic discount
6.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
PM
PM
Philip Morris International
Your Fair Value
US$
Current Price
US$166.60
0.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
56b
2015
2018
2021
2024
2025
2027
2030
Revenue US$56.3b
Earnings US$11.8b
Advanced
Set Fair Value